(2008). A rabbit model of atherosclerosis at carotid artery: MRI visualization and histopathological characterization.
(2009). Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles.
(2003). Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
(2006). Clinical and therapeutical implications of EPC biology in atherosclerosis.
(2003). Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
(2009). Detection and quantification of magnetically labeled cells by cellular MRI.
(2005). Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats.
(2007). Endothelial progenitor cells in health and atherosclerotic disease.
(2004). Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.
(2006). In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood.
(2006). In vivo detection of single cells by MRI.
(2007). In vivo MR imaging of bone marrow cells trafficking to atherosclerotic plaques.
(2007). In vivo MR tracking of mesenchymal stem cells in rat liver after intrasplenic transplantation.
(2011). In Vivo Serial MR imaging evaluates neointimal hyperplasia inhibited by intravenously transfused endothelial progenitor cells in carotid artery injured mice.
(2002). Inflammation in atherosclerosis.
(2009). Inhibited atherosclerotic plaque formation by local administration of magnetically labeled endothelial progenitor cells (EPCs) in a rabbit model.
(2003). Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.
(1991). Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.
(1990). Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.
(2003). Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.
(1997). Isolation of putative progenitor endothelial cells for angiogenesis.
(2009). Kastrup A
(2005). Long-term results of carotid stenting are competitive with surgery.
(2006). Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis.
(1993). Mouse model of arterial injury.
(2008). MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure.
(2004). MRI detection of single particles for cellular imaging.
(2000). Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the carotid artery of the apolipoprotein-E null mouse.
(2009). Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
(2004). Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
(2003). Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling.
(2010). Single Fe(2)O(3)-PLL labeled mouse spleenderived endothelial progenitor cell detection by 7.0T MR system.
(2003). Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma.
(2008). Vascular repair by endothelial progenitor cells.